BamSEC and AlphaSense Join Forces
Learn More

Pure Bioscience Inc

OTC: PURE    
Share price (12/20/24): $0.09    
Market cap (12/20/24): $9.508 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.1
from 8-K 30 pages Note Purchase Agreement
12/34/56
EX-10.1
from 8-K 25 pages Note Purchase Agreement
12/34/56
EX-10.1
from 8-K 30 pages Note Purchase Agreement
12/34/56
EX-10.1
from 8-K 27 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 17 pages Supply and License Agreement
12/34/56
EX-10.1
from 10-Q 28 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 26 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 5 pages Sublease Agreement
12/34/56
EX-10.1
from 8-K 3 pages Amendment to Consultant Agreement
12/34/56
EX-10.1
from 8-K 26 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 10 pages Consultant Agreement
12/34/56
EX-10.1
from 8-K 40 pages Certain Identified Information Contained in This Document, Marked by Brackets, Has Been Excluded Because the Information (I) Is Not Material and (II) Would Likely Cause Competitive Harm to the Registrant if Publicly Disclosed
12/34/56
EX-10.2
from 8-K 4 pages Pure Bioscience, Inc. Amendment to Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 26 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 26 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 4 pages First Amendment to Warrant to Purchase Common Stock
12/34/56
EX-10.1
from 8-K 4 pages Second Amendment to Employment Agreement
12/34/56
EX-10.2
from 8-K 11 pages Consultant Agreement
12/34/56
EX-10.1
from 8-K 28 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 5 pages Consulting Agreement
12/34/56